Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats
Authors:
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Adipocytokine Nampt and Its Product NMN Have No Effect on Beta-Cell Survival but Potentiate Glucose Stimulated Insulin SecretionPLOS ONE, 2013
- Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and PathophysiologyAnnual Review of Nutrition, 2012
- Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathwayJournal of Molecular Endocrinology, 2011
- Adipocyte–Brain: Crosstalk2010
- Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical MechanismsDiabetes, 2010
- Expression of Neuropeptide Y, Omentin and Visfatin in Visceral and Subcutaneous Adipose Tissues in Humans: Relation to Endocrine and Clinical ParametersObesity Facts, 2010
- Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cellsJournal of Molecular Endocrinology, 2009
- Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeCell Metabolism, 2007
- The Adipocyte as an Active Participant in Energy Balance and MetabolismGastroenterology, 2007
- Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of InsulinScience, 2005